Your browser doesn't support javascript.
loading
Polygenic scores for psychiatric disorders in a diverse postmortem brain tissue cohort.
Duncan, Laramie; Shen, Hanyang; Schulmann, Anton; Li, Tayden; Kolachana, Bhaskar; Mandal, Ajeet; Feng, Ningping; Auluck, Pavan; Marenco, Stefano.
Afiliação
  • Duncan L; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, 94305, USA. Laramied@Stanford.edu.
  • Shen H; Wu Tsai Neuroscience Institute, Stanford University, Stanford, CA, USA. Laramied@Stanford.edu.
  • Schulmann A; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, 94305, USA.
  • Li T; Epidemiology and Clinical Research Graduate Program, Stanford University, Stanford, CA, USA.
  • Kolachana B; Human Genetics Branch, NIMH-IRP, Bethesda, MD, 20892, USA.
  • Mandal A; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, 94305, USA.
  • Feng N; Human Brain Collection Core (HBCC), NIMH-IRP, Bethesda, MD, 20892, USA.
  • Auluck P; Human Brain Collection Core (HBCC), NIMH-IRP, Bethesda, MD, 20892, USA.
  • Marenco S; Human Brain Collection Core (HBCC), NIMH-IRP, Bethesda, MD, 20892, USA.
Neuropsychopharmacology ; 48(5): 764-772, 2023 04.
Article em En | MEDLINE | ID: mdl-36694041
A new era of human postmortem tissue research has emerged thanks to the development of 'omics technologies that measure genes, proteins, and spatial parameters in unprecedented detail. Also newly possible is the ability to construct polygenic scores, individual-level metrics of genetic risk (also known as polygenic risk scores/PRS), based on genome-wide association studies, GWAS. Here, we report on clinical, educational, and brain gene expression correlates of polygenic scores in ancestrally diverse samples from the Human Brain Collection Core (HBCC). Genotypes from 1418 donors were subjected to quality control filters, imputed, and used to construct polygenic scores. Polygenic scores for schizophrenia predicted schizophrenia status in donors of European ancestry (p = 4.7 × 10-8, 17.2%) and in donors with African ancestry (p = 1.6 × 10-5, 10.4% of phenotypic variance explained). This pattern of higher variance explained among European ancestry samples was also observed for other psychiatric disorders (depression, bipolar disorder, substance use disorders, anxiety disorders) and for height, body mass index, and years of education. For a subset of 223 samples, gene expression from dorsolateral prefrontal cortex (DLPFC) was available through the CommonMind Consortium. In this subgroup, schizophrenia polygenic scores also predicted an aggregate gene expression score for schizophrenia (European ancestry: p = 0.0032, African ancestry: p = 0.15). Overall, polygenic scores performed as expected in ancestrally diverse samples, given historical biases toward use of European ancestry samples and variable predictive power of polygenic scores across phenotypes. The transcriptomic results reported here suggest that inherited schizophrenia genetic risk influences gene expression, even in adulthood. For future research, these and additional polygenic scores are being made available for analyses, and for selecting samples, using postmortem tissue from the Human Brain Collection Core.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Transtorno Bipolar Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Transtorno Bipolar Idioma: En Ano de publicação: 2023 Tipo de documento: Article